StockComparison Logo
vs

GHC vs XENE

Comparison between Graham Holdings Co. - Class B (GHC, Company) and Xenon Pharmaceuticals Inc (XENE, Company).

GHC is from the Consumer Defensive sector, while XENE is from the Healthcare sector.

5-Year PerformanceXENE has outperformed GHC, delivering a return of +22.9% compared to +13.4%

GHC vs XENE - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
GHC
$4.97B
XENE
$4.96B
Max Drawdown
Winner
GHC
74.58%
XENE
90.43%
Sharpe Ratio
GHC
0.80
Winner
XENE
1.00
5Y Beta
Winner
GHC
0.81
XENE
0.95
Industry
GHC
Education & Training Services
XENE
Biotechnology
P/E Ratio
GHC
16.99
Winner
XENE
-11.03
Forward P/E
GHC
20.12
XENE
N/A
PEG Ratio
GHC
0.18
Winner
XENE
-0.27
Dividend Yield
GHC
0.63%
XENE
N/A
5Y Dividends CAGR
GHC
9.12%
XENE
N/A
5Y EPS CAGR
GHC
2.97%
Winner
XENE
40.27%
Debt to Equity
GHC
18.37%
Winner
XENE
0.00%
Free Cash Flow Yield
Winner
GHC
5.54%
XENE
-6.19%
P/S Ratio
Winner
GHC
0.99
XENE
727.44
P/B Ratio
Winner
GHC
1.04
XENE
3.81

GHC vs XENE - Historical Returns

Returns include dividend reinvestment.

1M
Winner
GHC
+6.02%
XENE
-5.27%
3M
Winner
GHC
+12.71%
XENE
-10.02%
6M
GHC
+5.61%
Winner
XENE
+18.25%
1Y
GHC
+24.93%
Winner
XENE
+58.84%
5Y(CAGR)
GHC
+13.43%
Winner
XENE
+22.87%
10Y(CAGR)
GHC
+10.05%
Winner
XENE
+21.88%
Max(CAGR)
GHC
+6.23%
Winner
XENE
+14.81%

GHC vs XENE - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearGHCXENE
2026+8.59%+17.10%
2025+27.93%+11.58%
2024+25.34%-12.71%
2023+14.97%+23.62%
2022-7.35%+24.82%
2021+20.94%+111.94%
2020-15.33%+12.10%
2019-1.32%+96.26%
2018+14.83%+119.48%
2017+7.60%-64.01%
2016+10.17%-3.27%
2015-8.11%-57.01%
2014+33.73%+88.10%
2013+79.28%N/A
2012+1.26%N/A
2011-12.40%N/A
2010+1.50%N/A
2009+8.55%N/A
2008-49.91%N/A
2007+6.72%N/A
2006-4.05%N/A
2005-19.91%N/A
2004+25.40%N/A
2003+6.46%N/A
2002+41.01%N/A
2001-11.27%N/A
2000+15.05%N/A
1999+4.39%N/A

GHC vs XENE Drawdown Comparison

The maximum drawdown for GHC was -67.56%, occurring on Mar 9, 2009. Recovery took 2488 trading sessions.

The maximum drawdown for XENE was -90.43%, occurring on Nov 14, 2017. Recovery took 1696 trading sessions.

The current GHC drawdown is -1.10%. The current XENE drawdown is -16.99%.

RankGHCXENE
#1-67.56%
Dec 29, 2004 - Nov 14, 2014
-90.43%
Jan 8, 2015 - Oct 4, 2021
#2-62.56%
Jul 30, 2019 - Jan 22, 2024
-43.59%
Feb 9, 2024 - Mar 9, 2026
#3-40.09%
Jul 7, 2015 - Apr 8, 2019
-34.08%
May 9, 2023 - Dec 22, 2023
#4-21.93%
Mar 2, 2001 - Apr 17, 2002
-30.14%
Nov 5, 2021 - Aug 4, 2022
#5-19.78%
Sep 26, 2025 - Jan 21, 2026
-25.87%
Nov 11, 2014 - Dec 11, 2014
#6-18.75%
Nov 10, 1999 - Dec 1, 2000
-18.40%
Mar 9, 2026 - Jun 8, 2026
#7-18.01%
Apr 30, 2002 - Aug 7, 2002
-17.08%
Mar 1, 2023 - May 3, 2023
#8-14.55%
Jul 26, 2024 - Sep 30, 2024
-16.98%
Aug 24, 2022 - Feb 13, 2023
#9-13.00%
Jan 21, 2026 - Mar 20, 2026
-11.44%
Oct 15, 2021 - Nov 2, 2021
#10-12.85%
Jan 6, 2003 - Nov 10, 2003
-11.09%
Dec 11, 2014 - Dec 29, 2014
#11-12.48%
Apr 2, 2025 - Aug 12, 2025
-9.36%
Feb 13, 2023 - Mar 1, 2023
#12-12.39%
Jun 8, 2004 - Nov 15, 2004
-8.58%
Jan 8, 2024 - Feb 8, 2024
#13-11.69%
Mar 16, 2015 - May 20, 2015
-8.27%
Aug 10, 2022 - Aug 24, 2022
#14-11.04%
Nov 8, 2024 - Feb 14, 2025
-6.08%
Dec 29, 2014 - Jan 7, 2015
#15-10.83%
Dec 9, 2014 - Jan 29, 2015
-4.89%
Dec 27, 2023 - Jan 8, 2024

Correlation

Correlation between GHC and XENE is 0.70 which considered as a moderate positive correlation - the stocks show some tendency to move together.

0.70
-101

Select Stocks to Compare